Neumora Therapeutics (NMRA) PT Lowered to $6 at Stifel
Tweet Send to a Friend
Stifel analyst Paul Matteis lowered the price target on Neumora Therapeutics (NASDAQ: NMRA) to $6.00 (from $26.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
